The Association of Donor Thyroid Hormone Supplementation on Heart Transplant Recipient Survival
Table 2
Donor characteristics.
Overall (N = 46542)
No donor THS (N = 17631)
Donor THS (N = 28911)
value
Donor age
32.29 (11.31)
32.28 (11.30)
32.30 (11.32)
0.877
Nonwhite donor
16085 (35%)
6188 (35%)
9897 (34%)
0.055
Donor BMI
27.23 (5.85)
27.24 (5.89)
27.23 (5.82)
0.756
Donor on inotropic support
21754 (49%)
8119 (49%)
13635 (48%)
0.091
Diabetic donor
1546 (3%)
519 (3%)
1027 (4%)
<0.001
Cause of death
Anoxia
11963 (26%)
4887 (28%)
7076 (24%)
<0.001
CVD/stroke
9334 (20%)
3780 (21%)
5554 (19%)
Trauma
23959 (51%)
8432 (48%)
15527 (54%)
CNS tumor
317 (1%)
132 (1%)
185 (1%)
Other
969 (2%)
400 (2%)
569 (2%)
Donor history of MI
396 (1%)
173 (1%)
223 (1%)
0.017
Donor history of drug use (any)
15823 (34%)
6032 (34%)
9791 (34%)
0.444
Donor LVEF
61.59 (7.11)
61.92 (7.17)
61.39 (7.07)
<0.001
Donor on steroid support
34399 (74%)
12607 (72%)
21792 (75%)
<0.001
BMI: body mass index; CVD: cardiovascular disease; CNS: central nervous system; MI: myocardial infarction; LVEF: left ventricular ejection fraction. Means (standard deviations) are presented for continuous variables. Counts (%) are presented for categorical variables.
